Japan's finance minister Katayama said she has been informed that GPIF's rule of an annual review of its baseline portfolio remains unchanged.

On July 15, at an online investor Q&A ahead of its STAR Market listing, Changxin Technology vice‑president and board secretary Yuan Yuan said the company’s fifth‑generation process technology platform and related products are currently in R&D. The platform uses an optimized multi‑exposure lithography technique to raise storage density and improve array performance; the R&D team is actively advancing related process and product development.

A-share traditional Chinese medicine sector staged a volatile rally in the afternoon; Pien Tze Huang neared its daily limit-up, with Tongrentang, Zhenbaodao, Panlong Pharmaceutical, Kangmei Pharmaceutical and Tasly also rising.